Michael Onuscheck

Michael Onuscheck is CEO and Chairman of Presidio Medical, a San Mateo clinical-stage neuromodulation company developing an ultra-low-frequency waveform platform aimed at chronic pain. He joined in September 2021 after two years on the board, returning to neuromodulation after leading Alcon's global businesses and, earlier, Boston Scientific's Neuromodulation division.